Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inhibrx Biosciences Inc (INBX)
NASDAQ:INBX
Inhibrx Biosciences Inc (INBX) Stock Price & Analysis
3 Followers
INBX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$12.60 - $18.95
Previous Close$13.56
Volume81.64K
Average Volume (3M)364.29K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$2.68M
Price to Earnings (P/E)―
Beta2.32
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding14,475,904
10 Day Avg. Volume321,809
30 Day Avg. Volume364,285
Standard Deviation0.27
R-Squared0.25
Alpha0.00334
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)134.13
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Inhibrx Biosciences Inc News
PremiumCompany Announcements
Inhibrx Biosciences Shares Latest Corporate Presentation Update
PremiumCompany Announcements
Inhibrx’s Strategic Financial Moves and Corporate Restructuring
Ownership Overview
25.12% Insiders
0.00% Mutual Funds
6.15% Other Institutional Investors
68.73% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
INBX FAQ
What was Inhibrx Biosciences Inc’s price range in the past 12 months?
Inhibrx Biosciences Inc lowest stock price was $12.60 and its highest was $18.95 in the past 12 months.
What is Inhibrx Biosciences Inc’s market cap?
Currently, no data Available
When is Inhibrx Biosciences Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Inhibrx Biosciences Inc’s earnings last quarter?
Currently, no data Available
Is Inhibrx Biosciences Inc overvalued?
According to Wall Street analysts Inhibrx Biosciences Inc’s price is currently Overvalued.
Does Inhibrx Biosciences Inc pay dividends?
Inhibrx Biosciences Inc does not currently pay dividends.
What is Inhibrx Biosciences Inc’s EPS estimate?
Inhibrx Biosciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Inhibrx Biosciences Inc have?
Inhibrx Biosciences Inc has 14,475,904 shares outstanding.
What happened to Inhibrx Biosciences Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Inhibrx Biosciences Inc?
Currently, no hedge funds are holding shares in INBX
---
Inhibrx Biosciences Inc Stock Smart Score
Company Description
Inhibrx Biosciences Inc
Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integrative approach to research and development to design differentiated therapeutic candidates. The company has four programs in clinical trials, of which three of the programs are for the treatment of various cancers, and one for the treatment of Alpha-1 Antitrypsin Deficiency.
---
Technical Analysis
---